Literature DB >> 2003997

Prevalence of common and dysplastic naevi in a Swedish population.

A Augustsson1, U Stierner, M Suurküla, I Rosdahl.   

Abstract

The naevus profile was examined in a Swedish population that was randomly selected from a census file. The participation rate was considered high at 82%. The number of common naevi (CN) and the prevalence of dysplastic naevi (DN) were investigated in 379 subjects (aged 30-50 years). The mean total body count of CN greater than or equal to 2 mm was 67 (range 1-300). As many as 22% of the population had 100 naevi or more and only 18% had less than 25. The counts were not influenced by age or sex. DN were diagnosed clinically in 18% (CI 14-22%) of the subjects and histologically in 8% (CI 5-11%). Subjects with dysplastic naevi had a significantly larger number of common naevi and a more sun-sensitive skin type than subjects without DN, P less than 0.001.

Entities:  

Mesh:

Year:  1991        PMID: 2003997     DOI: 10.1111/j.1365-2133.1991.tb00424.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

Review 1.  Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities.

Authors:  U Ringborg; B Lagerlöf; M Broberg; E Månsson-Brahme; A Platz; M Thörn
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

2.  A two-stage validation study for determining sensitivity and specificity.

Authors:  T D Tosteson; L Titus-Ernstoff; J A Baron; M R Karagas
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

3.  Evaluation of electrical impedance spectroscopy as an adjunct to dermoscopy in short-term monitoring of atypical melanocytic lesions.

Authors:  Hannah Ceder; Alexandra Sjöholm Hylén; Ann-Marie Wennberg Larkö; John Paoli
Journal:  Dermatol Pract Concept       Date:  2016-10-31

4.  High prevalence of skin diseases and need for treatment in a middle-aged population. A Northern Finland Birth Cohort 1966 study.

Authors:  Suvi-Päivikki Sinikumpu; Laura Huilaja; Jari Jokelainen; Markku Koiranen; Juha Auvinen; Päivi M Hägg; Erika Wikström; Markku Timonen; Kaisa Tasanen
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.